Механизмы межмикробных взаимодействий между пробиотическими микроорганизмами и *Helicobacter pylori*

Шавхатовна Исаева Гузель; Р.А.  Исаева

doi:10.36488/cmac.2023.3.225-238

Механизмы межмикробных взаимодействий между пробиотическими микроорганизмами и Helicobacter pylori

Клиническая микробиология и антимикробная химиотерапия. 2023; 25(3):225-238

Исаева Г.Ш., Исаева Р.А.

10.36488/cmac.2023.3.225-238

Helicobacter pylori микробиота пробиотики

Раздел

Болезни и возбудители

Тип

Обзор

Публикация

Клиническая микробиология и антимикробная химиотерапия. 2023; 25(3):225-238

Аннотация Авторы Литература PDF Статистика Репринты

Аннотация

В этом обзоре обобщены последние данные о механизмах межмикробных взаимодействий между пробиотическими микроорганизмами и Н. pylori. В обзоре рассмотрены вопросы влияния H. pylori на микробиоту ЖКТ, межвидовых взаимодействий микроорганизмов в составе микробных консорциумов, механизмы антагонистического действия пробиотических культур на H. pylori, а также анализ исследований применения пробиотиков в лечении хеликобактериоза. При этом останется много нерешенных вопросов о выборе видового состава пробиотического коктейля, дозировки, продолжительности терапии, механизмов антимикробного действия пробиотиков, также возможных негативных последствий такой терапии, что требует проведения дальнейших исследований.

Гузель Шавхатовна Исаева

guisaeva@rambler.ru

ФБУН «Казанский НИИ эпидемиологии и микробиологии» Роспотребнадзора, Казань, Россия
ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России, Казань, Россия

Исаева Р.А.

1. Nakamura M., Murayama S.Y., Rimbara E. Review: nonHelicobacter pylori Helicobacters. Microb Health Dis. 2022;4(3):723. DOI: 10.26355/mhd_20229_723
2. Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64: 1353-1367. DOI: 10.1136/gutjnl-2015-309252
3. O’Connor A. Review: treatment of Helicobacter pylori infection 2022. Microb Health Dis. 2022;4(3):e713. DOI: 10.26355/mhd_20229_713
4. Azadbakht S., Moayyedkazemi A., Azadbakht S., Fard S.A., Soroush S. Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: a cohort study. Ann Med Surg (Lond). 2022;78:103824. DOI: 10.1016/j.amsu.2022.103824
5. Tian L., Yao Y., Yin L., Wang L., An Z., Kang L., et al. Direct detection of antibiotic resistance in Chinese Helicobacter pylori clinical isolates by sequencing-based approach. J Healthc Eng. 2022;2022:6436256. DOI: 10.1155/2022/6436256
6. Vanden Bulcke A., Waked B., Haems L., Lambrecht G., Hervent A. S., Alliet G., Baert F., et al. Antimicrobial resistance of Helicobacter pylori in West Flanders – Belgium: an observational cross-sectional study. Acta Clin Belg. 2022;77(2):360-367. DOI: 10.1080/17843286.2021.1872307
7. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6-30. DOI: 10.1136/gutjnl-2016-312288
8. Malfertheiner P., Megraud F., Rokkas T., Gisbert P.J., Liou J.M., Schulz C., et al. Management of Helicobacter pylori infection – the Maastricht VI/Florence Consensus Report. Gut. 2022; gutjnl-2022-327745. DOI: 10.1136/gutjnl-2022-327745
9. Stoma I.O. Microbiome in medicine: a guidance for doctors. GEOTAR-Media 2020. 320 p. Russian. (Стома И.О. Микробиом в медицине: руководство для врачей. Москва. ГЭОТАР-Медиа, 2020. 320 с.)
10. Schulz C., Schutte K., Malfertheiner P. Helicobacter pylori and other gastric microbiota in gastroduodenal pathologies. Dig Dis. 2016;34:210-216. DOI: 10.1159/000443353
11. Zilberstein B., Quintanilha A.G., Santos M.A., Pajecki D., Moura E.G, Alves P.R.A., et al. Digestive tract microbiota in healthy volunteers. Clinics (Sao Paulo). 2007;62(1):4754. DOI: 10.1590/s1807-59322007000100008
12. Delgado S., Cabrera-Rubio R., Mira A., Suarez A., Mayo B. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol. 2013;65(3):763-772. DOI: 10.1007/s00248-013-0192-5
13. Bik E.M., Eckburg P.B., Gill S.R., Nelson K.E., Purdom E.A., Francois F., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006;103(3):732-737. DOI: 10.1073/pnas.0506655103
14. Li X.X., Wong G.L., To K.F., Wong V.W.S., Lai L.H., Chow D.K.L., et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal antiinflammatory drug use. PLoS One. 2009;4(11):e7985. DOI: 10.1371/journal.pone.0007985
15. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262-1267. DOI: 10.1126/science.1223813
16. Maldonado-Contreras A., Goldfarb K.C., Godoy-Vitorino F., Karaoz U., Contreras M., Blaser M.J., et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5(4):574-579. DOI: 10.1038/ismej.2010.149
17. Shin C.M., Kim N., Ji Hyun Park J.H., Lee D.H. Changes in gastric corpus microbiota with age and after Helicobacter pylori eradication: a long-term follow-up study. Front Microbiol. 2021;11:621879. DOI: 10.3389/fmicb.2020.621879
18. Espinoza J.L., Matsumoto A., Tanaka H., Matsumura I. Gastric microbiota: an emerging player in Helicobacter pyloriinduced gastric malignancies. Cancer Lett. 2018;414:147152. DOI: 10.1016/j.canlet.2017.11.009
19. Schulz C., Schutte K., Koch N., Vilchez-Vargas R., WosOxley M.L., Oxley A.P.A., et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut. 2018;67(2):216225. DOI: 10.1136/gutjnl-2016-312904
20. Aebischer T., Fischer A., Walduck A., Schlotelburg C., Lindig M., Schreiber S., et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol. 2006;46(2):221229. DOI: 10.1111/j.1574-695X.2005.00024.x
21. Kienesberger S., Cox L.M., Livanos A., Zhang X.S., Chung, J., Guillermo, I., et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14(6):1395-1407. DOI: 10.1016/j.celrep.2016.01.017
22. Myllyluoma E., Ahlroos T., Veijola L., Rautelin H., Tynkkynen S., Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents. 2007;29(1):66-72. DOI: 10.1016/j.ijantimicag.2006.08.034
23. Jakobsson H.E., Jernberg C., Andersson A.F., SjolundKarlsson M., Jansson J.K., Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5(3):e9836. DOI: 10.1371/journal.pone.0009836
24. Chen L., Xu W., Lee A., He J., Huang B., Zheng W., et al. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial. EBioMedicine. 2018;35:87-96. DOI: 10.1016/j.ebiom.2018.08.028
25. Olekhnovich E.I., Manolov A.I., Samoilov A.E., Prianichnikov N.A., Malakhova, M.V., Tyakht A.V., et al. Shifts in the human gut microbiota structure caused by quadruple Helicobacter pylori eradication therapy. Front Microbiol. 2019;10:1902. DOI: 10.3389/fmicb.2019.01902
26. Smirnov V.V., Kovalenko N.K., Podgorskii S., Sorokulova I.B. Probiotics based on live cultures of microorganisms. Mikrobiologicheskij zhurnal. 2002;64(4):62-80. Russian. (Смирнов В.В., Коваленко Н.К., Подгорский В.С, Сорокулова И.Б. Пробиотики на основе живых культур микроорганизмов. Микробиологический журнал. 2002;64(4):62-80.)
27. Araya M., Morelli L., Reid G., Sanders M.E., Stanton C., Pineiro M., et al. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, 2002. Available at: www.mhlw.go.jp/file/05-Shingikai-11121000-IyakushokuhinkyokuSoumuka/0000197343.pdf. Accessed August 2023.
28. Jezewska-Frackowiak J., Seroczynska K., Banaszczyk J., Jedrzejczak G., Zylicz-Stachula A., Skowron P.M. The promises and risks of probiotic Bacillus species. Acta Biochim Pol. 2018;65(4):509-519. DOI: 10.18388/abp.2018_2652
29. Ryan K.A., Jayaraman T., Daly P., Canchaya C., Curran S., Fang F., et al. Isolation of lactobacilli with probiotic properties from the human stomach. Lett Appl Microbiol. 2008;47(4):269-274. DOI: 10.1111/j.1472765x.2008.02416.x
30. Chen Y.H., Tsai W.H., Wu H.Y., Chen C.Y., Yeh W.L., Chen Y.H., et al. Probiotic spp. act against Helicobacter pylori-induces inflammation. J Clin Med. 2019;8(1):90. DOI: 10.3390/jcm8010090
31. Zhao K., Xie Q., Xu D., Guo Y., Tao X., Wei H., et al. Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells. J Biosci Bioeng. 2018;126(4):458-463. DOI: 10.1016/j.jbiosc.2018.04.003
32. Sun L., Zhao H., Liu L., Wu X., Gao Q., Zhao Y. Effects of Lactobacillus on the inhibition of Helicobacter pylori growth. Biotechnol Biotechnol Equip. 2018;32(6):15331540. DOI: 10.1080/13102818.2018.1515599
33. Bhatia S.J., Kochar N., Abraham P., Nair N.G., Mehta A.P. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol. 1989;27(10):2328-2330. DOI: 10.1128/jcm.27.10.2328-2330.1989
34. Aiba Y., Nakano Y., Koga Y., Takahashi K., Komatsu Y. A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. Microbiologyopen. 2015;4(3):465474. DOI: 10.1002/mbo3.252
35. Aiba Y., Ishikawa H., Tokunaga M., Komatsu Y. AntiHelicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088. FEMS Microbiol Lett. 2017;364(11). DOI: 10.1093/femsle/fnx102
36. Zheng P.X., Fang H.Y., Yang H.B., Tien N.Y., Wang M.C., Wu J.J. Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. J Microbiol Immunol Infect. 2016;49(2):168-174. DOI: 10.1016/j.jmii.2014.04.014
37. Lesbros-Pantoflickova D., Corthesy-Theulaz I., Blum A.L. Helicobacter pylori and probiotics. J Nutr. 2007;137(3 Suppl. 2):812S-8S. DOI: 10.1093/jn/137.3.812S
38. Batdorj B., Trinetta V., Dalgalarrondo M., Prevost H., Dousset X., Ivanova I., et al. Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp lactis T31, isolated from Mongolian yoghurt: Inhibitory activity on food-borne pathogens foolborne pathogens. J Appl Microbiol. 2007;103(3):584593. DOI: 10.1111/j.1365-2672.2007.03279.x
39. Kim N.N., Kim W.J., Kang S.S. Anti-biofilm effect of crude bacteriocin derived from Lactobacillus brevis DF01 on Escherichia coli and Salmonella Typhimurium. Food Control. 2018;98:274-280. DOI: 10.1016/j.foodcont.2018.11.004
40. Kim T.S., Hur J.W., Yu M.A., Cheigh C.I., Kim K.N., Hwang J.K., et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot. 2003;66(1):3-12. DOI: 10.4315/0362-028x-66.1.3
41. Boyanova L., Gergova G., Markovska R., Yordanov D., Mitov I. Bacteriocin-like inhibitory activities of seven Lactobacillus delbrueckii subsp. bulgaricus strains against antibiotic susceptible and resistant Helicobacter pylori strains. Lett Appl Microbiol. 2017;65(6):469-474. DOI: 10.1111/lam.12807
42. Urrutia-Baca V.H., Escamilla-Garcia E., de la GarzaRamos M.A., Tamez-Guerra P., Gomez-Flores R., UrbinaRios C.S. In vitro antimicrobial activity and downregulation of virulence gene expression on Helicobacter pylori by reuterin. Probiotics Antimicrob Proteins. 2018;10(2):168175. DOI: 10.1007/s12602-017-9342-2
43. Mukai T., Asasaka T., Sato E., Mori K., Matsumoto M., Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. Fems Immunol Med Microbiol. 2002;32(2):105-110. DOI: 10.1111/j.1574-695X.2002.tb00541.x
44. De Klerk N., Maudsdotter L., Gebreegziabher H., Sa_ roj S.D., Eriksson B., Eriksson O.S., et al. Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression. Infect Immun. 2016;84(5):1526-1535. DOI: 10.1128/IAI.00163-16
45. Sakarya S., Gunay N. Saccharomyces boulardii expresses neuraminidase activity selective for alpha2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells. APMIS. 2014;122(10):941-950. DOI: 10.1111/apm.12237
46. Mack D., Ahrne S., Hyde L., Wei S., Hollingsworth M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003;52(6):827-833. DOI: 10.1136/gut.52.6.827
47. Byrd J.C., Yunker C.K., Xu Q.S., Sternberg L.R., Bresalier R.S. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology. 2000;118(6):1072-1079. DOI: 10.1016/s0016-5085(00)70360-x
48. Hanisch F.G., Bonar D., Schloerer N., Schroten H. Human trefoil factor 2 isa lectin that binds α-GlcNAc-capped mucinglycans with antibiotic activity against Helicobacter pylori. J Biol Chem. 2014;289(40):27363-27375. DOI: 10.1074/jbc.M114.597757
49. Suez J., Zmora N., Segal E., Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716729. DOI: 10.1038/s41591-019-0439-x
50. Yang Y.J., Chuang C.C., Yang H.B., Lu C.C., Sheu B.S. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFKB pathways. BMC Microbiol. 2012;12:38. DOI: 10.1186/1471-2180-12-38
51. Thiraworawong T., Spinler J.K., Werawatganon D., Klaikeaw N., Venable S.F., Versalovic J., et al. Antiinflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection. Helicobacter. 2014;19(2):144-155. DOI: 10.1111/hel.12105
52. Song H., Zhou L., Liu D., Ge L., Li Y. Probiotic effect on Helicobacter pylori attachment and inhibition of inflammation in human gastric epithelial cells. Exp Ther Med. 2019;18(3):1551-1562. DOI: 10.3892/etm.2019.7742
53. Wiese M., Eljaszewicz A., Andryszczyk M., Gronek S., Gackowska L., Kubiszewska I., et al. Immunomodulatory effects of Lactobacillous plantarum and Helicobacter pylori CagA+ on the expression of selected superficial molecules on monocyte and lymphocyte and the synthesis of cytokines in whole blood culture. J Physiol Pharmacol. 2012;63(3):217-224. PMID: 22791635.
54. Zhou C., Ma F.Z., Deng X.J., Yuan H., Ma H.S. Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol. 2008;14(32):5090-5095. DOI: 10.3748/wjg.14.5090
55. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu Rev Microbiol. 2001;55:165-199. DOI: 10.1146/annurev.micro.55.1.165
56. Sun J., Daniel R., Wagner-Dobler I., Zeng A.P. Is autoinducer-2 a universal signal for interspecies communication: a comparative genomic and phylogenetic analysis of the synthesis and signal transduction pathways. BMC Evol Biol. 2004;4:36. DOI: 10.1186/1471-21484-36
57. Joyce E.A., Bassler B.L., Wright A. Evidence for a signaling system in Helicobacter pylori: detection of a luxS-encoded autoinducer. J Bacteriol. 2000;182(13):3638-3643. DOI: 10.1128/JB.182.13.3638-3643.2000
58. Stark R.M., Gerwig G.J., Pitman R.S., Potts L.F., Williams N.A., Greenman J., et al. Biofilm formation by Helicobacter pylori. Lett Appl Microbiol. 1999;28:121126. DOI: 10.1046/j.1365-2672.1999.00481.x
59. Yonezawa H., Osaki T., Kurata S., Zaman C., Hanawa T., Kamiya S. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25(Suppl. 1):S90-4. DOI: 10.1111/j.14401746.2009.06213.x
60. Yonezawa H., Osaki T., Kurata S., Fukuda M., Kawakami H., Ochiai K., et al. Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation. BMC Microbiol. 2009;9:197. DOI: 10.1186/1471-2180-9197
61. Williams J.C., McInnis K.A., Testerman T.L. Adherence of Helicobacter pylori to abiotic surfaces is influenced by serum. Appl Environ Microbiol. 2008;74(4):1255-1258. DOI: 10.1128/AEM.01958-07
62. Swidsinski A., Loening-Baucke V., Herber A. Mucosal flora in Crohn’s disease and ulcerative colitis – an overview. J Physiol Pharmacol. 2009;60(Suppl. 6):61-71. PMID: 20224153.
63. Carron M.A., Tran V.R., Sugawa C., Coticchia J.M. Identification of Helicobacter pylori biofilms in human gastric mucosa. J Gastrointest Surg. 2006;10(5):712-717. DOI: 10.1016/j.gassur.2005.10.019
64. Cellini L., Grande R., Di Campli E., Traini T., Di Giulio M., Lannutti S.N., et al. Dynamic colonization of Helicobacter pylori in human gastric mucosa. Scand J Gastroenterol. 2008;43(2):178-185. DOI: 10.1080/00365520701675965
65. Coticchia J.M., Sugawa C., Tran V.R., Gurrola J., Kowalski E., Carron M.A. Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease. J Gastrointest Surg. 2006;10(6):883889. DOI: 10.1016/j.gassur.2005.12.009
66. Yonezawa H., Osaki T., Hojo F., Kamiya S. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin. Microb Pathog. 2019;132:100-108. DOI: 10.1016/j.micpath.2019.04.030
67. Attaran B., Falsafi T., Ghorbanmehr N. Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics. World J Gastroenterol. 2017;23(7):1163-1170. DOI: 10.3748/wjg.v23.i7.1163
68. Yonezawa H., Osaki T., Hanawa T., Kurata S., Ochiai K., Kamiya S. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. PLoS One. 2013;8(9):e73301. DOI: 10.1371/journal.pone.0073301
69. Ge X., Cai Y., Chen Z., Gao S., Geng X., Li Y., et al. Bifunctional enzyme spot is involved in biofilm formation of Helicobacter pylori with multidrug resistance by upregulating efflux pump Hp1174 (gluP). Antimicrob Agents Chemother. 2018;62(11):e00957-18. DOI: 10.1128/AAC.00957-18
70. Hathroubi S., Servetas S.L., Windham I., Merrell D.S., Ottemann K.M. Helicobacter pylori biofilm formation and its potential role in pathogenesis. Microbiol Mol Biol Rev. 2018;82(2):e00001-18. DOI: 10.1128/MMBR.00001-18
71. Hathroubi S., Zerebinski J., Ottemann K.M. Helicobacter pylori biofilm involves a multigene stress-biased response, including a structural role for flagella. mBio. 2018;9(5):e01973-18. DOI: 10.1128/mBio.01973-18
72. Cammarota G., Branca G., Ardito F., Ianiro G., Cianci R., Torelli R, et al. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol. 2010;8(9):817-820.e3. DOI: 10.1016/j.cgh.2010.05.006
73. Song H., Zhang, J., Qu J., Liu J., Yin P., Zhang G., et al. Lactobacillus rhamnosus GG microcapsules inhibit Escherichia coli biofilm formation in coculture. Biotechnol Lett. 2019;41(8-9):1007-1014. DOI: 10.1007/s10529019-02694-2
74. Merino L., Trejo F.M., De Antoni G., Golowczyc M.A. Lactobacillus strains inhibit biofilm formation of Salmonella sp. isolates from poultry. Food Res Int. 2019;123:258265. DOI: 10.1016/j.foodres.2019.04.067
75. Jung S., Park O.J., Kim A.R., Ahn K.B., Lee D., Kum K.Y., et al. Lipoteichoic acids of lactobacilli inhibit Enterococcus faecalis biofilm formation and disrupt the preformed biofilm. J Microbiol. 2019;57(4):310-315. DOI: 10.1007/s12275-019-8538-4
76. Gonzalez Moreno M., Trampu A., Di Luca M. Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J Antimicrob Chemother. 2017;72(11):3085-3092. DOI: 10.1093/jac/dkx265
77. Moghadam S.S., Khodaii Z., Zadeh F.S., Ghooshchian M., Aghmiyuni F.Z., Shabestari M.T. Synergistic or antagonistic effects of probiotics and antibiotics-alone or in combination-on antimicrobial-resistant Pseudomonas aeruginosa isolated from burn wounds. Arch Clin Infect Dis. 2018;3(3):e63121. DOI: 10.5812/archcid.6312
78. Yang J., Yang H. Effect of Bifidobacterium breve in combination with different antibiotics on Clostridium difficile. Front Microbiol. 2018;9:2953. DOI: 10.3389/fmicb.2018.02953
79. Lv Z., Wang B., Zhou X., Wang F., Xie Y., Zheng H., et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: a meta-analysis. Exp Ther Med. 2015;9(3):707-716. DOI: 10.3892/etm.2015.2174
80. Tong J.L., Ran Z.H., Shen J., Zhang C.X., Xiao S.D. Metaanalysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007;25(2):155-168. DOI: 10.1111/j.13652036.2006.03179.x
81. Wang Z.H., Gao Q.Y., Fang J.Y. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2013;47(1):25-32. DOI: 10.1097/MCG.0b013e318266f6cf
82. Zhang M.M., Qian W., Qin Y.Y., He J., Zhou Y.H. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21(14):4345-4357. DOI: 10.3748/wjg.v21.i14.4345
83. Zheng X., Lyu L., Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis. Rev Esp Enferm Dig. 2013;105(8):445-453. DOI: 10.4321/s113001082013000800002
84. Zhu R., Chen K., Zheng Y.Y., Zhang H.W., Wang J.S., Xia Y.J., et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. World J Gastroenterol. 2014;20(47):18013-18021. DOI: 10.3748/wjg.v20.i47.18013
85. Dang Y., Reinhardt J.D., Zhou X., Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One. 2014;9(11):e111030. DOI: 10.1371/journal.pone.0111030
86. McFarland L.V., Huang Y., Wang L., Malfertheiner P. Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016;4(4):546-561. DOI: 10.1177/2050640615617358
87. McFarland L.V., Malfertheiner P., Huang Y., Wang L. Metaanalysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events. World J Metaanal. 2015;3(2):97-117. DOI: 10.13105/wjma.v3.i2.97
88. Gotteland M., Poliak L., Cruchet S., Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr. 2005;94(12):17471751. DOI: 10.1111/j.1651-2227.2005.tb01848.x
89. Losurdo G., Cubisino R., Barone M., Principi M, Leandro G., Ierardi E., et al. Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis. World J Gastroenterol. 2018;24(1):139-149. DOI: 10.3748/wjg.v24.i1.139
90. Rosania R., Minenna M.F., Giorgio F., Facciorusso A., De Francesco V., Hassan C., et al. Probiotic multistrain treatment may eradicate Helicobacter pylori from the stomach of dyspeptics: a placebo-controlled pilot study. Inflamm Allergy Drug Targets. 2012;11(3):244-249. DOI: 10.2174/187152812800392698
91. Ianiro G., Bruno G., Lopetuso L., Beghella F.B., Laterza L., D’Aversa F., et al. Role of yeasts in healthy and impaired gut microbiota: the gut mycome. Curr Pharm Des. 2014;20(28):4565-4569. DOI: 10.2174/13816128113196660723
92. Szajewska H., Horvath A., Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015;41(12):12371245. DOI: 10.1111/apt.13214
93. Myllyluoma E., Kajander K., Mikkola H., Kyronpalo S., Rasmussen M., Kankuri E., et al. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Dig Liver Dis. 2007;39(6):516-523. DOI: 10.1016/j.dld.2007.02.015
94. Francavilla R., Lionetti E., Castellaneta S.P., Magista A.M., Maurogiovanni G., Bucci N., et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter. 2008;13(2):127-134. DOI: 10.1111/j.1523-5378.2008.00593.x
95. Zagari R.M., Pozzato P., Martuzzi C., Fuccio L., Martinelli G., Roda E., et al. 13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter. 2005; 10(6):615-619. DOI: 10.1111/j.1523-5378.2005.00358.x
96. Dore M.P., Bibbo S., Pes G.M., Francavilla R., Graham D.Y. Role of probiotics in Helicobacter pylori eradication: lessons from a study of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a proton-pump inhibitor. Can J Infect Dis Med Microbiol. 2019;2019:3409820. DOI: 10.1155/2019/3409820
97. Tyagi A.K., Prasad S. Commentary: probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Front Microbiol. 2015;6:433. DOI: 10.3389/fmicb.2015.00433
98. Delgado S., Leite A.M.O., Ruas-Madiedo P., Mayo B. Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Front Microbiol. 2014;5:766. DOI: 10.3389/fmicb.2014.00766
99. Mehling H., Busjahn A. Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans. Nutrients. 2013;5(8):3062-3073. DOI: 10.3390/nu5083062
100. Holz C., Busjahn A., Mehling H., Arya S., Boettner M., Habibi H., et al. Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: a pilot study. Probiotics Antimicrob Proteins. 2015;7(2):91-100. DOI: 10.1007/s12602-014-9181-3
101. Fonseca J.D., Fernandes C.C., Cunha L.F., Zung S. Efficacy and safety of Lactobacillus reuteri in Helicobacter pylori infection. Gastroenterology. 2019;156(6):S-531-S-532. DOI: 10.1016/S0016-5085(19)38215-0
102. Sykora J., Valeckova K.N., Amlerova J., Siala K., Dede P., Watkins S., et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol. 2005;39(8):692-698. DOI: 10.1097/01.mcg.0000173855.77191.44
103. Deguchi R., Nakaminami H., Rimbara E., Noguchi N., Sasatsu M., Suzuki T., et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol. 2012;27(5):888-892. DOI: 10.1111/j.14401746.2011.06985.x
104. Sachdeva A., Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol. 2009;21(1):4553. DOI: 10.1097/MEG.0b013e32830d0eff
105. Eslami M., Yousefi B., Kokhaei P., Moghadas A.J., Moghadam B.S., Arabkari V., et al. Are probiotics useful for therapy of Helicobacter pylori diseases? Comp Immunol Microbiol Infect Dis. 2019;64:99-108. DOI: 10.1016/j.cimid.2019.02.010
106. Okamoto T., Sasaki M., Tsujikawa T., Fujiyama Y., Bamba T., Kusunoki M. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol. 2000;35(5):341-346. DOI: 10.1007/s005350050358
107. Yonezawa H., Osaki T., Hanawa T., Kurata S., Zaman C., Woo T.D.H., et al. Destructive effects of butyrate on the cell envelope of Helicobacter pylori. J Med Microbiol. 2012;61:582-589. DOI: 10.1099/jmm.0.039040-0
108. Takahashi M., Taguchi H., Yamaguchi H., Osaki T., Kamiya S. Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. J Med Microbiol. 2000;49(7):635-642. DOI: 10.1099/0022-1317-49-7-635
109. Imase K., Takahashi M., Tanaka A., Tokunaga K., Sugano H., Tanaka M., et al. Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota. Microbiol Immunol. 2008;52(3):156161. DOI: 10.1111/j.1348-0421.2008.00026.x
110. Gareau M.G., Sherman P.M., Walker W.A. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7(9):503-514. DOI: 10.1038/nrgastro.2010.117
111. Wu L., Wang Z., Sun G., Peng L., Lu Z., Yan B., et al. Effects of anti-H.pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer. Sci Rep. 2019;9(1):12874. DOI: 10.1038/s41598-01949415-3
112. Yang C., Liang L., Lv P., Liu L., Wang S., Wang Z., et al. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial. Helicobacter. 2021;26(6):e12856. DOI: 10.1111/hel.12856
113. Chen M.J., Chen C.C., Huang Y.C., Tseng C.C., Hsu J.T., Lin Y.F., et al. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota – a doubleblind, placebo-controlled, randomized trial. Helicobacter. 2021;26(6):e12857. DOI: 10.1111/hel.12857
114. Naghibzadeh N., Salmani F., Nomiri S., Tavakoli T. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial. BMC Gastroenterol. 2022;22(1):107. DOI: 10.1186/s12876-022-02187-z
115. Hablass F.H., Lashen S.A., Alsayed E.A. Efficacy of lactoferrin with standard triple therapy or sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. Turk J Gastroenterol. 2021;32(9):742749. DOI: 10.5152/tjg.2021.20923
116. Viazis N., Argyriou K., Kotzampassi K., Christodoulou D.K., Apostolopoulos P., Georgopoulos S.D., et al. A fourprobiotics regimen combined with a standard Helicobacter pylori-eradication treatment reduces side effects and increases eradication rates. Nutrients. 2022;14(3):632. DOI: 10.3390/nu14030632
117. Cifuentes S.G., Prado M.B., Fornasini M., Cohen H., Baldeуn M.E., Cоrdenas P.A. Saccharomyces boulardii CNCM I-745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy. Helicobacter. 2022;27(2):e12870. DOI: 10.1111/hel.12870
118. Guillemard E., Poirel M., Schafer F., Quinquis L., Rossoni C., Keicher C., et al. A randomised, controlled trial: effect of a multi-strain fermented milk on the gut microbiota recovery after Helicobacter pylori therapy. Nutrients. 2021;13(9):3171. DOI: 10.3390/nu13093171
119. Venkatesan T. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebocontrolled trial. Nutr Clin Pract. 2008;23(6):662-663. DOI: 10.1177/0884533608326323
120. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al., and Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659. DOI: 10.1016/S01406736(08)60207-X
121. Chicherin I.Yu., Pogorel`skij I.P., Lundovskix I.A., Pozolotina N.V., Gavrilov K.E., Darmov I.V., et al. The role of probiotic microorganisms in translocation of intestinal microbiota in the peritoneal cavity and the bloodstream of experimental animals. Infekcionny`e bolezni. 2015;13(4):43-52. Russian. (Чичерин И.Ю., Погорельский И.П., Лундовских И.А, Позолотина Н.В., Гаврилов К.Е., Дармов И.В. и соавт. Роль пробиотических микроорганизмов в транслокации кишечной микробиоты в брюшную полость и кровоток экспериментальных животных. Инфекционные болезни. 2015;13(4):43-52.)
122. Chicherin I.Yu., Pogorel`skij I.P., Lundovskix I.A., Darmov I.V., Gavrilov K.E., Gorshkov A.S., et al. Translocation of intestinal microbiota. Zhurnal mezhdunarodnoj mediciny. 2016;2(19):24-31. Russian. (Чичерин И.Ю., Погорельский И.П., Лундовских И.А., Дармов И.В., Гаврилов К.Е., Горшков А.С. и соавт. Транслокация кишечной микробиоты. Журнал международной медицины. 2016; 2(19):24-31.)

Просмотров

0 Аннотация

0 PDF

0 Цитирования

Механизмы межмикробных взаимодействий между пробиотическими микроорганизмами и Helicobacter pylori

Аннотация

Просмотров

Поделились

Процитировали Crossref